학술논문
Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)
Document Type
article
Author
Source
Hematological Oncology. 41(S2)
Subject
Language